<DOC>
	<DOC>NCT00567164</DOC>
	<brief_summary>The purpose of this study is to determine whether the study drug is safe and effective.</brief_summary>
	<brief_title>Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ</brief_title>
	<detailed_description>The primary efficacy parameter is the number of observed unintended pregnancy during 1 year of treatment. Secondary efficacy parameter include bleeding parameters and menstrual related symptoms Safety parameters included assessment of adverse events, laboratory evaluations.</detailed_description>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Drospirenone</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Betadex</mesh_term>
	<criteria>Healthy women between 18 and 45 requesting oral contraception. Smokers may not exceed 35 years of age. The use of steroidal oral contraceptives, or any drug that could alter oral contraception metabolism will be prohibited during the study.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Oral Contraception</keyword>
	<keyword>Birth Control pill</keyword>
	<keyword>Healthy women requesting oral contraception</keyword>
	<keyword>Contraceptive efficacy</keyword>
</DOC>